Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
Kazuhisa Nakashima, Yuichi Ozawa, Haruko Daga, Hisao Imai, Motohiro Tamiya, Takaaki Tokito, Takahisa Kawamura, Hiroaki Akamatsu, Yuko Tsuboguchi, Toshiaki Takahashi, Nobuyuki Yamamoto, Keita Mori, Haruyasu Murakami
Topics & Concepts
OsimertinibT790MMedicineInternal medicineLung cancerOncologyClinical endpointClinical trialEpidermal growth factor receptorAdenocarcinomaPhases of clinical researchSurgeryCancerGefitinibErlotinibLung Cancer Treatments and MutationsLung Cancer Research StudiesColorectal Cancer Treatments and Studies